Assessment of Myeloperoxidase and Oxidative α1-Antitrypsin in Patients on Hemodialysis | Zendy

Hirokazu Honda | Zendy; Masashi Ueda | Zendy; Shiho Kojima | Zendy; Shinichi Mashiba | Zendy; Yuki Hirai | Zendy; Nozomu Hosaka | Zendy; Hiroki Suzuki | Zendy; Masanori Mukai | Zendy; Makoto Watanabe | Zendy; Keiko Takahashi | Zendy; Kanji Shishido | Zendy; Tadao Akizawa | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Assessment of Myeloperoxidase and Oxidative α1-Antitrypsin in Patients on Hemodialysis

Author(s) -

Hirokazu Honda,

Masashi Ueda,

Shiho Kojima,

Shinichi Mashiba,

Yuki Hirai,

Nozomu Hosaka,

Hiroki Suzuki,

Masanori Mukai,

Makoto Watanabe,

Keiko Takahashi,

Kanji Shishido,

Tadao Akizawa

Publication year - 2009

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.02280508

Subject(s) - myeloperoxidase , medicine , hemodialysis , oxidative stress , gastroenterology , logistic regression , erythrocyte sedimentation rate , albumin , immunology , inflammation

The present study assesses the effects of the oxidative stress marker, myeloperoxidase (MPO), and the possible MPO-related oxidative stress marker, oxidative alpha(1)-antitrypsin (oxAT), on carotid intima-media thickness (CIMT) and protein-energy wasting (PEW) in patients on hemodialysis (HD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research